In America’s healthcare industry, the corporate intent is not healing—it is monetizing illness.Every patient is a line item, every diagnosis a revenue code, every crisis an earnings opportunity.
Insurance companies don’t compete on care—they compete on how effectively they can deny it.Proprietary AI systems and review departments are optimized to reject claims, delay prior authorizations, and exhaust patients into paying out-of-pocket or giving up treatment altogether.
The longer the delay, the higher the savings—for the corporation, not the patient.
Hospitals once run by medical professionals are now managed like Wall Street portfolios.
Private equity firms buy them, strip assets, lay off staff, and replace full-time nurses with lower-paid contract labor, all while raising prices.
ER wait times grow longer, care quality drops, but investor reports glow with “cost efficiencies.”
Even during record profits, layoffs are part of the business model:
• Nurses, lab techs, and administrative staff are cut to reduce “labor expenses,” forcing the remaining workforce to do more with less, increasing burnout and medical errors.
• These same corporations then boast to shareholders about “improved productivity metrics,” while patient safety quietly erodes.
• In 2023–2024, major hospital systems and insurers announced tens of thousands of job cuts—even after reporting billions in surplus—just to feed the next round of stock buybacks and executive bonuses.
Pharmaceutical giants are no better.They raise prices on essential dr-gs year after year, not to cover R&D, but to satisfy shareholder demands.A life-saving medication that costs a few dollars to manufacture is sold for hundreds or thousands, because corporate law shields them from treating health as anything but a commodity.
When reform threatens this machine, the industry unleashes a tidal wave of lobbying.
In 2022 alone, the healthcare sector spent over $700 million influencing lawmakers—more than the oil, defense, and tech industries combined.
The goal is simple: keep the system complex, privatized, and profitable.
This is not a system that accidentally fails patients.It succeeds at its true mission:
• To extract maximum revenue from sickness
• To shrink labor costs through mass layoffs and outsourcing
• To keep life-saving care just expensive enough to guarantee continuous demand
In this model, health is bad for business, and healing is a loss on the balance sheet.
That is the corporate intent—designed, refined, and executed without shame.